Articles with public access mandates - Anthony E LangLearn more
Not available anywhere: 105
Parkinson's disease
LV Kalia, AE Lang
The Lancet 386 (9996), 896-912, 2015
Mandates: Canadian Institutes of Health Research, Parkinson's UK, Parkinson's …
Gastrointestinal dysfunction in Parkinson's disease
A Fasano, NP Visanji, LWC Liu, AE Lang, RF Pfeiffer
The Lancet Neurology 14 (6), 625-639, 2015
Mandates: Canadian Institutes of Health Research, Parkinson's Foundation, USA
Disease‐modifying strategies for Parkinson's disease
LV Kalia, SK Kalia, AE Lang
Movement Disorders 30 (11), 1442-1450, 2015
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in …
O Rascol, CJ Fitzer-Attas, R Hauser, J Jankovic, A Lang, JW Langston, ...
The Lancet Neurology 10 (5), 415-423, 2011
Mandates: Canadian Institutes of Health Research
Toward a redefinition of Parkinson's disease
MB Stern, A Lang, W Poewe
Movement disorders 27 (1), 54-60, 2012
Mandates: Canadian Institutes of Health Research
Gut–brain axis and the spread of α‐synuclein pathology: vagal highway or dead end?
DP Breen, GM Halliday, AE Lang
Movement disorders 34 (3), 307-316, 2019
Mandates: National Health and Medical Research Council, Australia, Canadian Institutes …
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
D Berg, AE Lang, RB Postuma, W Maetzler, G Deuschl, T Gasser, ...
The Lancet Neurology 12 (5), 514-524, 2013
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
α-Synuclein-based animal models of Parkinson's disease: challenges and opportunities in a new era
NP Visanji, JM Brotchie, LV Kalia, JB Koprich, A Tandon, JC Watts, ...
Trends in neurosciences 39 (11), 750-762, 2016
Mandates: Parkinson's UK
Predictors of deterioration in health‐related quality of life in Parkinson's disease: results from the DATATOP trial
C Marras, MP McDermott, PA Rochon, CM Tanner, G Naglie, AE Lang, ...
Movement Disorders 23 (5), 653-659, 2008
Mandates: US National Institutes of Health
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
RMA de Bie, CE Clarke, AJ Espay, SH Fox, AE Lang
The Lancet Neurology 19 (5), 452-461, 2020
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Parkinson's disease in the Western Pacific Region
SY Lim, AH Tan, A Ahmad-Annuar, C Klein, LCS Tan, RL Rosales, ...
The Lancet Neurology 18 (9), 865-879, 2019
Mandates: Canadian Institutes of Health Research, National Medical Research Council …
Stereotypies: a critical appraisal and suggestion of a clinically useful definition
MJ Edwards, AE Lang, KP Bhatia
Movement Disorders 27 (2), 179-185, 2012
Mandates: Canadian Institutes of Health Research
Involvement of the cerebellothalamocortical pathway in Parkinson disease
Z Ni, AD Pinto, AE Lang, R Chen
Annals of neurology 68 (6), 816-824, 2010
Mandates: Canadian Institutes of Health Research
Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets
AJ Espay, PA LeWitt, RA Hauser, A Merola, M Masellis, AE Lang
The Lancet Neurology 15 (9), 954-966, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PD
JM Miyasaki, J Long, D Mancini, E Moro, SH Fox, AE Lang, C Marras, ...
Parkinsonism & related disorders 18, S6-S9, 2012
Mandates: Canadian Institutes of Health Research
Extrastriatal dopaminergic dysfunction in Tourette syndrome
TDL Steeves, JH Ko, DM Kideckel, P Rusjan, S Houle, P Sandor, AE Lang, ...
Annals of Neurology: Official Journal of the American Neurological …, 2010
Mandates: Canadian Institutes of Health Research
Alimentary, my dear Watson? The challenges of enteric α‐synuclein as a Parkinson's disease biomarker
NP Visanji, C Marras, LN Hazrati, LWC Liu, AE Lang
Movement Disorders 29 (4), 444-450, 2014
Mandates: Canadian Institutes of Health Research, Parkinson's Foundation, USA
Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond
C Klein, SA Schneider, AE Lang
Movement disorders: official journal of the Movement Disorder Society 24 (14 …, 2009
Mandates: Canadian Institutes of Health Research, German Research Foundation
Management of impulse control disorders in Parkinson's disease: controversies and future approaches
M Samuel, M Rodriguez‐Oroz, A Antonini, JM Brotchie, K Ray Chaudhuri, ...
Movement Disorders 30 (2), 150-159, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment
E Roze, AE Lang, M Vidailhet
Current Opinion in Neurology 31 (4), 484-490, 2018
Mandates: Canadian Institutes of Health Research, Parkinson's Foundation, USA
Publication and funding information is determined automatically by a computer program